Movement Alert｜DUALITYBIO-B Rises 5.22% in Regular Trading, UBS Initiates Coverage with Buy Rating as Interim Results Approach

Market Focus

Aug 21

On August 21, DUALITYBIO-B rose 5.22% in regular trading, trading at HKD 197.5/share, with turnover of HKD 48.06 million.

On the news front, UBS recently initiated coverage on DUALITYBIO-B with a Buy rating and a target price of HKD 320, implying approximately 62% upside from the current share price. UBS noted the stock trades at only 0.7x risk-adjusted peak sales ratio, well below the peer median of 1.6x, and projects DB-1311 peak sales of RMB 38.3 billion, above market consensus of RMB 28.6 billion. Additionally, China Merchants Securities, Soochow Securities, and China Galaxy Securities have each initiated coverage with positive ratings in recent weeks.

Meanwhile, the company is scheduled to release its interim results on August 28, covering the six months ended June 30. Combined with continuous share buybacks since May — including repurchases on June 5, June 10, June 16, and June 26 — institutional bullish sentiment and earnings release expectations are forming a positive resonance for the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1103697001"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1103697001\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1103697001?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-21 10:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103697001","market":"hk","top_or_hot":-1,"title":"Movement Alert｜DUALITYBIO-B Rises 5.22% in Regular Trading, UBS Initiates Coverage with Buy Rating as Interim Results Approach","media":"Market Focus","content":"<p><p>On August 21, DUALITYBIO-B rose 5.22% in regular trading, trading at HKD 197.5/share, with turnover of HKD 48.06 million.</p><p>On the news front, UBS recently initiated coverage on DUALITYBIO-B with a Buy rating and a target price of HKD 320, implying approximately 62% upside from the current share price. UBS noted the stock trades at only 0.7x risk-adjusted peak sales ratio, well below the peer median of 1.6x, and projects DB-1311 peak sales of RMB 38.3 billion, above market consensus of RMB 28.6 billion. Additionally, China Merchants Securities, Soochow Securities, and China Galaxy Securities have each initiated coverage with positive ratings in recent weeks.</p><p>Meanwhile, the company is scheduled to release its interim results on August 28, covering the six months ended June 30. Combined with continuous share buybacks since May — including repurchases on June 5, June 10, June 16, and June 26 — institutional bullish sentiment and earnings release expectations are forming a positive resonance for the stock.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜DUALITYBIO-B Rises 5.22% in Regular Trading, UBS Initiates Coverage with Buy Rating as Interim Results Approach</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜DUALITYBIO-B Rises 5.22% in Regular Trading, UBS Initiates Coverage with Buy Rating as Interim Results Approach\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-21 10:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 21, DUALITYBIO-B rose 5.22% in regular trading, trading at HKD 197.5/share, with turnover of HKD 48.06 million.</p><p>On the news front, UBS recently initiated coverage on DUALITYBIO-B with a Buy rating and a target price of HKD 320, implying approximately 62% upside from the current share price. UBS noted the stock trades at only 0.7x risk-adjusted peak sales ratio, well below the peer median of 1.6x, and projects DB-1311 peak sales of RMB 38.3 billion, above market consensus of RMB 28.6 billion. Additionally, China Merchants Securities, Soochow Securities, and China Galaxy Securities have each initiated coverage with positive ratings in recent weeks.</p><p>Meanwhile, the company is scheduled to release its interim results on August 28, covering the six months ended June 30. Combined with continuous share buybacks since May — including repurchases on June 5, June 10, June 16, and June 26 — institutional bullish sentiment and earnings release expectations are forming a positive resonance for the stock.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09606","symbol_name":"映恩生物-B","start_time":0,"source_url":"","article_id":"1103697001","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103697001","pubTimestamp":1787279913,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 21, DUALITYBIO-B rose 5.22% in regular trading, trading at HKD 197.5/share, with turnover of HKD 48.06 million.On the news front, UBS recently initiated coverage on DUALITYBIO-B with a Buy...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09606":"映恩生物-B"},"translate_title":"走势警报|DUALITYBIO-B 常规交易上涨 5.22%，瑞银启动买入评级作为中期业绩方法","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09606":1},"content_text":"On August 21, DUALITYBIO-B rose 5.22% in regular trading, trading at HKD 197.5/share, with turnover of HKD 48.06 million.On the news front, UBS recently initiated coverage on DUALITYBIO-B with a Buy rating and a target price of HKD 320, implying approximately 62% upside from the current share price. UBS noted the stock trades at only 0.7x risk-adjusted peak sales ratio, well below the peer median of 1.6x, and projects DB-1311 peak sales of RMB 38.3 billion, above market consensus of RMB 28.6 billion. Additionally, China Merchants Securities, Soochow Securities, and China Galaxy Securities have each initiated coverage with positive ratings in recent weeks.Meanwhile, the company is scheduled to release its interim results on August 28, covering the six months ended June 30. Combined with continuous share buybacks since May — including repurchases on June 5, June 10, June 16, and June 26 — institutional bullish sentiment and earnings release expectations are forming a positive resonance for the stock.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}